This project delves into the financial intricacies of Banco Safra, a Brazilian bank, focusing on currency risk management in the context of an international pharmaceutical investment. The scenario involves Banco Safra providing a loan from the Central Bank of Brazil to a Brazilian pharmaceutical company for an investment in Switzerland. The project thoroughly examines the associated currency risks, including the use of foreign exchange contracts, analysis of spot and future rates, and the application of International Financial Reporting Standards (IFRS). It explores the role of stock exchanges and capital money markets in mitigating these risks and emphasizes strategies to protect Brazil's currency. The project also covers the legal and accounting frameworks relevant to the transaction, providing a comprehensive understanding of the financial and regulatory landscape. The project is supported by a presentation that outlines the bank's profile, financial performance, the loan details, the pharmaceutical company's investment, and the country risks associated with investing in Switzerland, all with the goal of ensuring the bank and the country's financial stability.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
